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PENILAIAN PENGETAHUAN, SIKAP DAN PENEPATAN TERHADAP 
GANSPANDUAN AMALAN KLINIKAL (GINA 2011) DIKALANGAN 
DOKTOR DAN KOS YANG BERKAITAN DENGAN RAWATAN ASMA 
ABSTRAK 
literatur yang sedia ada mencadangkan bahawa ketidakpatuhan doktor terhadap garis 
panduan GINA ini adalah salah satu faktor utama yang menyumbang kepada 
kawalan asma yang kurang memuaskan. Kajian ini melibatkan 27 doktor dari Jabatan 
Kecemasan dan 6 doktor dari Jabatan Respiratori yang terlibat dalam satu kajian 
yang telah dijalankan di Hospital Pulau Pinang (HPP). Matlamatnya adalah untuk 
menilai pengetahuan doktor, sikap terhadap garis panduan amalan klinikal asma 
(CPG), faktor yang mempengaruhi pengurusan asma, ketetapan doktor terhadap garis 
panduan  GINA 2011 dan kos langsung yang berkaitan dengan rawatan asma di HPP. 
Pengetahuan, sikap doktor terhadap CPG (GINA 2011) dan faktor-faktor yang 
memberi kesan kepada pengurusan asma telah dinilai melalui SATU soal selidik. 
Preskripsi yang ditulis oleh 27 doktor di Jabatan Kecemasan dan 6 doktor di Jabatan 
Respiratori diteliti . Sebanyak 810 preskripsi pesakit dari Jabatan Kecemasan dan 
180 preskripsi pesakit dari Jabatan Respiratori diambil (30 preskripsi bagi setiap 
doktor yang didaftar) .  Preskripsi yang diteliti telah dikelaskan sama ada sebagai " 
mematuhi " atau "tidak mematuhi " dengan CPG ( GINA 2011). Satu ratus lapan 
puluh (180) pesakit di Jabatan Respiratori telah dianalisa sekali lagi pada lawatan 
susulan. Nilai spirometri ( FEV1 ) dicatatkan pada lawatan susulan telah 
dibandingkan dengan nilai spirometry pada lawatan pertama. SPSS 20 telah 
digunakan untuk analisis data di mana p nilai < 0.05 dianggap signifikan secara 
statistik. Dua puluh dua (22) doktor dari Jabatan Kecemasan ( 81.5 %) dan kesemua 
enam (6) doktor dari Jabatan Respiratori mempunyai pengetahuan yang cukup dalam 
CPG (GINA 2011). Doktor dari Jabatan Kecemasan dan Jabatan Respiratori 
xx 
 
mempunyai ketetapan positif terhadap CPG (GINA 2011) dengan menunjukkan skor 
min sebanyak 20.8 (SD ± 1.6) mata dan 20.33 (SD ± 2.55 ) masing-masing pada 
skala yang mempunyai 25 mata. Satu korelasi yang tidak signifikan secara statistik 
telah diperhatikan di antara pengetahuan dan amalan skor doktor dari Jabatan 
Kecemasan ( 0.13 , p = 0.49) dan doktor dari Jabatan Respiratori '(0.53 , p = 0.27). 
Enam ratus dua puluh lapan (628) pesakit (77.5 %) dari Jabatan Kecemasan dan 143 
pesakit ( 78.9 %) dari Jabatan Respiratori menerima farmakoterapi yang mematuhi 
garis panduan. Kawalan asma pesakit pernafasan mempunyai hubungan yang 
signifikan dengan jantina (p = 0.015 ). Nilai spirometri dari lawatan kedua pesakit 
berbeza daripada lawatan pertama pesakit secara statistik (P < 0.001) . Kos preskripsi 
bagi peasakit asma yang terkawal namun tidak patut kepada garis panduan GINA 
(RM = 10.39 ) adalah lebih tinggi daripada kos preskripsi bagi peasakit asma yang 
terkawal dan patut kepada garis panduan GINA (RM = 9.18) di Jabatan Kecemasan 
manakala kos purata preskripsi kepatuhan (RM = 70.80 ) pesakit dari Jabatan 
Respiratori adalah lebih tinggi daripada kos purata ketidakpatuhan preskripsi (RM = 
13.74 ). 
Daripada 180 pesakit asma dari Jabatan Respiratori, seramai 158 (87.7%) pesakit 
berjaya mencapai kawalan asma yang baik. Antara pesakit yang berjaya dirawat, 124 
(78.4%) pesakit menerima farmakoterapi yang mematuhi garis panduan, manakala 
34 (21.6%) pesakit tidak menerima farmakoterapi yang mematuhi garis panduan. 
Ketidakpatuhan doktor terhadap garis panduan dan berdasarkan pengalaman peribadi 
menyebabkan 34 (21.6%) pesakit asma berjaya dirawati dan telah menjimatkan 
4.51% daripada kos langsung perawatan asma di jabatan pernafasan. 
Pengetahuan dan kepatuhan doktor dengan CPG (GINA 2011) menunjukkan tahap 
yang baik secara keseluruhan diperhatikan di HPP. 
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EVALUATION OF DOCTOR’S KNOWLEDGE, ATTITUDE, ADHERENCE 
TO CLINICAL PRACTICE GUIDELINE (GINA 2011) 
RECOMMENDATIONS AND COST ASSOCIATED WITH ASTHMA 
TREATMENT 
ABSTRACT 
The existing literature suggests that doctors’ divergence from GINA guidelines is 
one of the major contributing factor for poor asthma control. The present study 
includes 27 doctors from the emergency department and 6 doctors from the 
respiratory department in study that was conducted at Hospital Pulau Pinang (HPP). 
Its aim was to evaluate doctors’ knowledge, attitude towards asthma clinical practice 
guideline (CPG), factors affecting asthma management, practices on GINA 2011 
guideline and direct cost associated with asthma treatment at HPP. Doctor’s 
knowledge, attitude towards CPG (GINA 2011) and factors affecting asthma 
management were evaluated through a questionnaire.  
Prescriptions written by enrolled 27 emergency and 6 respiratory department doctors 
were noted. A total of 810 patients prescriptions from emergency and 180 patients 
prescription from respiratory department were noted (30 prescriptions per enrolled 
doctor).The noted prescriptions were classified either as “adhered” or “non-adhered” 
with CPG (GINA 2011). One hundred and eighty (180) patients in respiratory 
department were followed for second visit. Spirometry values (FEV1) noted on 
second visit were differentiated from spirometry values at first visit.  SPSS 20 was 
used for data analysis. Where a p value of <0.05 was considered statistically 
significant. Twenty two (22) emergency department doctors (81.5%) and all 6 
respiratory department doctors had adequate knowledge of CPG (GINA 2011). 
Twenty six (26) emergency and all 6 respiratory department doctors had positive 
attitude towards CPG (GINA 2011) with mean scores of 20.8 (SD ± 1.6) points and 
xxii 
 
20.33 (SD ± 2.55) points respectively on a 25 point scale. A statistical insignificant 
correlation was observed between emergency doctors’ (0.13, p=0.49) and respiratory 
doctors’ (0.53, p=0.27) knowledge and practice scores. Six hundred and twenty eight 
(628) patients (77.5%) from emergency department and 143 patients (78.9%) from 
respiratory department received guideline adhered pharmacotherapy. Respiratory 
patients asthma control had a significant relation with gender (p=0.015). Spirometry 
values from patient second visit were statistically different from patients first visit (P 
<0.001).  Cost of non adhered prescription for mild asthma patients (RM= 10.39) 
was higher than adhered mild asthma prescription (RM=9.18) at emergency 
department whereas the average cost of adhered prescription (RM=70.80) of 
respiratory department patients was higher than average non adhered prescription 
(RM=13.74). 
Of 180 asthma patients from respiratory department, 158 (87.7%) patient treatment 
outcome was successful. Among successfully treated patients, 124 (78.4%) patients 
received guideline adhered pharmacotherapy where as 34 (21.6%) patients did not 
receive guideline adhered pharmacotherapy. Doctor deviance from guideline based 
on personal experience and patient condition among successfully treated 34 (21.6%) 
asthma patients saved 4.51% of direct asthma cost at respiratory department. 
 An overall good level of doctors’ knowledge and adherence with CPG (GINA 2011) 
was observed at HPP. 
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Chapter 1 
Introduction 
1.1 Knowledge, attitude and practice (KAP) studies 
The KAP studies evaluates the existing knowledge, attitude and practices of a 
specific population that elaborates what is known, believed and accomplished by that 
specific population about a particular area of interest (WHO, 2008). Three main 
pillars of a KAP studies are as follows  
1.1.1 Knowledge 
Knowledge is defined as ability to acquire information through experience, skills and 
comprehension i.e. understanding a subject (Lakhan et al., 2010). Knowledge of 
health behaviour is considered to be beneficial. However, does not automatically 
mean that this behaviour will be followed. The degree of knowledge assessed by the 
survey helps to locate areas where information and education efforts remain to be 
exerted. 
 1.1.2 Attitude  
Attitude is the ability to respond in a particular way in a particular situation i.e 
perceived idea towards subject (Lakhan et al., 2010). Attitudes are connected to the 
individual‘s knowledge, emotions and values and consequently it might change from 
negative to positive and vice versa. As a result of studying attitude we can identify 
the emotional attitude/evaluation of individuals towards survey issues 
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1.1.3 Practices 
Practice is the ability to demonstrate knowledge and attitudes that lead to actions i.e. 
practical application of knowledge and attitude (Lakhan et al., 2010). Studying 
knowledge and attitude is not enough without studying existing practices. One of the 
advantages of KAP studies is that they provide a possibility to identify the practice 
model of population towards study issue in detail. 
KAP studies gain popularity due to their ability to generalise small results to large 
population. Moreover, simple methodology and easy interpretation of results is 
another wide spread utilization of KAP studies (Launiala, 2009). KAP studies tent to 
reveal not only characteristic traits in knowledge, attitude and behaviours about 
health related to religious, social, traditional factors, but also help identify factors 
that are often the source of misconceptions or misunderstandings that may represent 
obstacles to the activities we like to implement and potential barriers to behavioural 
changes (The KAP survey model, 2011). 
1.2 Clinical practice guidelines (CPG) 
Clinical practice guidelines are defined as ―systemic developed statements to assist 
practitioners and patient decisions about appropriate health care for specific clinical 
circumstances‖ (Field et al., 1990). Clinical quality is achieved by developing a 
system that utilizes multi disciplinary approach in implementing appropriate 
practices, involves patient convince and participation in clinical decision making. 
Variation in practices regarding diagnosis, treatment and prevention of disease due to 
uncertainty, biases and difference of opinion affects clinical quality (Eddy, 1984). To 
change clinical practices and to line them up with evidence based medicine (EBM), 
multiple strategies including management, regulation and education have been 
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implied (Browman et al., 1995; Woolf, 1990). Clinical practice guidelines (CPG) are 
one of many strategies that are applied to improve clinical quality (Woolf et al., 
1999). 
The objective of clinical practice guideline (CPG) is to achieve effective and 
efficient patient care, educate practitioners and patients, to assess and assure quality 
of care and guide allocation of health resources (Tan, 2006). Properly developed 
guidelines bring EBM into practice; reduce irrational practices, harmful interventions 
and make sure of best possible outcomes with cost effectiveness (Culleton, 2009). 
The delay in implementing research finding in clinical practice results in suboptimal 
care. On average, it takes 17 years to integrate facts found in clinical trials into 
clinical practices and even then, evidence is not incorporated as it should be (Carroll, 
2002). The effective and systemic way of bringing and practicing these evidences 
into clinical practices is the development and dissemination of CPG (Grimshaw et 
al., 2005). Clinical practice guidelines which were initially based on expert opinion 
are now considered to be systemically developed and evidence based (Lohr et al., 
1998). Clinical practice guideline should be valid, reliable, clinically applicable and 
flexible, developed through multidisciplinary process, continuously updated and 
documented (Field et al., 1990; Tan, 2006). The skills and resources required for the 
development of CPG are usually not available to individuals or a single health care 
organization, due to this reason CPG are developed by specialized national and 
international institutions (Ollenschläger et al., 2004). 
1.3 Need for emergence of clinical practice guidelines 
With the advancements in mid of twentieth century, traditional private and hospital 
practice in almost every part of the world began to face increasing pressure for 
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standardization. Numerous innovations as a result of medical research created serious 
dilemmas even as they offered physicians new therapeutic tools. Moreover, 
individual clinical judgement was becoming visibly inadequate to accommodate with 
recent advancements in medical sciences. 
In the light of recent advancements in new therapeutic agents and an attempt to 
preserve professional autonomy in the face of administrative pressure or as a way for 
groups and institutions to compete in the market place, therefore a need for clinical 
practice guideline emerged (Weisz et al., 2007). 
In the past it has been a traditional approach by the clinicians to order all the 
diagnostic procedures that might have helped in clarifying patient‘s condition and 
could help them in identifying appropriate treatment regimens. However, this 
traditional view ignores stubborn economic facts that make resources finite (Fowkes 
et al., 1984). Hence a need of clinical practice guideline emerged that would strive to 
provide a standardized clinical approach in treating patients with an added benefit at 
a socially acceptable cost. 
1.4 Impact of clinical practice guideline 
Number of CPG are developed, widely disseminated and regularly updated in almost 
every field of medicine. For improving the delivery of quality care to achieve the 
best possible outcomes, the systemic dissemination and successful implementation of 
guideline is of utmost importance (Lugtenberg et al., 2009). 
Existing literature suggests that most of the time successful implementation of 
guideline resulted in better quality of care and improved patient outcome. Successful 
implementation of guidelines is developed by Dutch college of General practitioners 
on the management of asthma and chronic obstructive pulmonary disease (COPD) 
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resulted in significant improvement in lung function and respiratory symptoms (Jans 
et al., 2001). In a multi centre, observational study conducted in six European 
countries, adherence to European guidelines on the management of congestive heart 
failure (CHF) was strongly and independently correlated with fewer CHF 
cardiovascular hospitalization rates (Komajda et al., 2005).  Similarly Hypertension 
control was significantly better in high risk cardiovascular patients treated by a group 
of physicians who had received training from European Society of Hypertension 
guideline (Asmar et al., 2007). Feder and colleagues while conducting a randomized 
controlled trial in general practices reported that the use of local guidelines improved 
the management of diabetes and asthma (Feder et al., 1995).  
1.5 Clinical practice guideline for asthma management 
In order to improve asthma management, reduce practice variation and provide cost 
beneficial therapy of guidelines for management of asthma have been developed and 
disseminated in various countries around the world. Various major guidelines for 
management of asthma include Global initiative for Asthma (GINA) guideline for 
the management of asthma (GINA, 2011), British thoracic society guideline for 
management of asthma, (BTS/SIGN Asthma guideline, 2011), Guideline for the 
diagnosis and management of asthma 2007, National Heart, Lung and blood institute 
(Expert panel report 3, 2007), Asthma model of care 2011, Government of Western 
Australia (Asthma Model of Care, 2012). A joint venture of Malaysian Thoracic 
society, Ministry of health Malaysia and Academy of medicine of Malaysia 
developed and published guidelines for asthma management in 1997 which was last 
updated in 2002 (Minestry of Health Malaysia, 2012). Despite the availability and 
dissemination of asthma management guidelines, literature review suggests the 
existence of wide gaps between guideline recommendations and actual clinical 
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practice (Guidry et al., 1992; Doerschug et al., 1999; Salmeron et al., 2001; O'Dowd 
et al., 2003; Robinson et al., 2003). 
1.6 Factors affecting guideline adherence 
1.6.1 Doctor knowledge of guideline adherence 
Doctors‘ awareness and familiarity with guideline is the initial step to translate 
guideline into clinical practices (Cabana et al., 1999; Pathman et al., 1996). Studies 
conducted in this regard have shown awareness of guideline among doctors, has 
improved their adherence with the guideline (El-Solh et al., 2011; Ikeda et al., 2006). 
The relationship between guideline awareness and their adherence is not straight 
forward. Holland et al., 2008 concluded that even though 945 of doctors were 
familiar with guideline recommendations most of them showed poor adherence. 
1.6.2 Doctor attitude towards guideline 
According to Cabana et al., (1999) attitude has an important role in guideline 
adherence in clinical practice. Similarly, doctor‘s intent to use clinical practice 
guideline can be attributed to their attitude towards them (Limbert et al., 2002). The 
use of guideline can be predicted from attitude of doctors (Kortteisto et al., 2010) 
which can be determined by various factors, such as their knowledge about 
guidelines, past clinical experience and outcomes of their practice (Clerc et  al., 
2011). 
1.6.3 Doctor demographics 
Sarrell et al., (2002) studied the compliance of primary care doctors to asthma 
guideline concluded that younger doctors attended the educational programs more 
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than their senior colleagues and were likely to adhere to asthma guideline. Apart 
from doctor age and experience studies indicate that doctor gender and specialty also 
affects guideline adherence (Fams et al, 2002; Holmes et al., 2004) 
1.6.4 Patient related factors 
Patient related factors that affect the guideline adherence are complex and involve 
social, demographic and behavioural issues. Inconvenience with treatment (Tashkin, 
1995), laziness and carelessness (Bosley et al., 1995), unwilling to adopt life style 
moreover social issues such as large family size and chaotic home environment 
affects patients adherence to regimen, hence further complexes the matter. 
1.6.5 Practices setting 
Placing written reminder and computer based tools at practice setting increase 
guideline adherence (Goethe et al., 1997). Similarly factors such as financial 
constraints, lack of training and lack of continuing medical education are few of the 
many factors that contribute to guideline adherence (Rashidian et al., 2008). 
1.7 Asthma 
Asthma is the chronic inflammatory disorder of the airway in which many cells and 
cellular elements play a role. The chronic inflammation associated with airway hyper 
responsiveness that leads to recurrent episodes of wheezing, breathlessness, chest 
tightness, and coughing particularly at night or in the early morning. These episodes 
are associated with widespread, but variable airflow obstruction within the lung that 
is often reversible either spontaneously or with treatment (Eric et al., 2011). 
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1.8 Epidemiology of asthma 
Asthma is the most common chronic disease among children and is prevalent 
globally (WHO, 2013) approximately three hundred million people are suffering 
from asthma, this figure is expected to rise to four hundred million by year 2025 
(Price et al., 2006). Two hundred and fifty thousand people die annually due to 
asthma; almost all these deaths are avoidable (Price et al., 2006). Over 80 % asthma 
deaths occur in lower and lower middle income countries.  In the United States, the 
prevalence of asthma has increased from 7.3 % in 2001 to 8.4% in 2010 (Akinbami 
et al., 2012). In 2010, 25.7 million people had asthma in the US, of which 7 million 
were aged less than 18 years, more than half (53 %) of people suffering from asthma 
had acute exacerbation and accounted for 3447 deaths. Moreover, hospitalized 
patients due to asthma were 1.5 times higher among females (Akinbami et al., 2012). 
According to global burden of asthma report, there are nearly 30 million people 
affected with asthma in Scandinavia, the UK, Ireland and Western Europe. The 
prevalence of asthma is higher in urban areas than suburban and rural areas 
throughout Europe. In response to health survey regarding asthma attacks during last 
12 months in Europe, prevalence was highest in France (7 %), Romania reported to 
be least (1.5 %). In the same survey, asthma was more commonly reported in females 
(4.3 %) then to males (3.3%). The largest disparity among gender was noted in 
Turkey (5 % & 2.5 %) (OECD, 2012). 
Asthma is a chronic condition responsible for disability, utilizes high medical 
resources and affects quality of life. Asthma affects both children and adults with 
different intensities. Multiple factors are responsible for the development and 
triggering of an asthmatic episode including genetic factors. The incidence of asthma 
is estimated between 2.65 to 4/1000 per year.  In children less than 5 years, the 
9 
 
incidence of asthma is estimated to be 8.1 to 14/1000 per year for boys and 4.3 to 
9/1000 per year, in girls this difference in gender tends to disappear in adulthood. 
The incidence of asthma over 25 years is estimated at 2.1/1000 per year (Chung, 
1995). The prevalence of asthma varies globally and ranges from 0.7 % in Macau to 
18.4 % in Scotland (Worldwide variations in the prevalence of asthma symptoms, 
1998). Studies indicate epidemiology of exacerbation of asthma attack are linked to 
multiple factors, epidemic of asthma exacerbations in Barcelona was linked to 
exposure of atmospheric soybean dust released during cargo handling (Antó et al., 
1989). In Northern Hemisphere, asthma exacerbation in school going children in 
September was related to seasonal Rhinovirus infection (Sears et al., 2007).  
In a survey of asthmatics in 8 regions of Asia Pacific it was observed that only 13.6 
% of asthma patients used corticosteroids despite half of them had persistent asthma 
(Lai, 2003). Asthma mortality and morbidity is related with under use of objective 
medication, under diagnosis and inappropriate supervision. Overall, 51.4 % of 
respondents had daytime symptoms, whereas 44.3 % reported sleep disturbances. 
About 26.5 % of adults and 36.5 % of children had missed their work or school 
because of asthma during the past one year. Moreover, 46.3 % of the respondents 
have been hospitalized and had an emergency visit during the previous one year. 
In Malaysia, asthma is a common cause of hospital admission and emergency visits. 
According to National Morbidity and health survey, the prevalence of self-reported 
asthma in Malaysia was 4.2 % (Rugayah et al., 1997). The prevalence of asthma 
reported at Negreri Sembilan was 7.1%, Kelantan was 3.9%, Johar was 4.3% and at 
Sarawak was 4.6% (Norsian 2008, Izamin et al., 2008, Rohayah 2008, Asri 2008). 
Generally rural areas had higher prevalence of asthma (4.5 %) when compared to 
urban areas (4.0 %). The prevalence of asthma in children aged 13-14 years is 9.6 %. 
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The survey also reports that only 36.1 % of adult asthma patients had ever had their 
peak flow measurement. Mild asthma was reported in 87.3 % patients, 9.9 % had 
moderate asthma and 2.7 % of patients had severe asthma (Rugayah et al., 1997). 
The prevalence of asthma in Malaysia among children is 13.8 %, the prevalence of 
chronic cough and persistent wheezing was higher among Indian children (p< 0.05) 
(Azizi, 1990). 
1.9 Pathophysiology of asthma 
Asthma is an inflammatory disorder of the airway that involves several inflammatory 
cells and multiple mediators. There are two main events that are associated with 
asthma. 
1.9.1 Bronchoconstriction 
Bronchoconstriction is defined as narrowing of airway in the lungs. During an 
asthma attack, the airway narrows and produces excessive mucus making it harder to 
breath. In response to certain stimuli, postganglionic parasympathetic fibres release 
acetylcholine which binds to muscarinic receptors resulting in smooth muscle 
contraction causing spasm (James, 2005). 
1.9.2 Bronchial inflammation 
Inhaled allergens that find their way to inner airway are ingested by antigen 
presenting cells (APC). APC present these allergens to immune cells and activate 
TH2 cells in asthmatic patients. This series of events results in activation of humoral 
immune system which produces antibodies against inhaled allergens. Further 
exposure to inhaled allergens activates humoral response resulting in inflamed 
airway (Cohn et al., 2004).  
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1.10 Factors influencing in development and expression of asthma 
Factors that influence the risk of asthma can be categorized as those that influence 
the development of asthma, other may aid in triggering of asthma. The former 
include host factors that are primarily genetic whereas environmental factors 
influence the latter one (Figure 1.1).  
Figure 1.1: Factors influencing development and expression of asthma 
 
 
Factors influencing 
development of asthma 
 
 
 
1.Genetic 
Asthma is heritable component; data 
shows multiple genes may be involved 
un pathogenesis of asthma (Holloway et 
al., 1999)  
2.Obesity 
Obese people with asthma have lower 
lung function and more co-morbidity 
(Shore, 2008). 
3.Gender 
The prevalence of asthma is twice as 
greater in boys than in girls prior to age 
14. As children get older the difference 
in prevalence of asthma narrows and by 
adulthood the prevalence of asthma is 
greater in women than in man ( Ibrahim 
, 2006) 
1. Allergens 
House dust mite, allergens, cat 
dander and aspergillus mold are risk 
factors for the development of 
asthma in children up to 3 years 
(Wahn et al., 1997)  
2. Infection 
Forty percent of children infected by 
Respiratory syncytical virus (RSV) 
have shown to have asthma like 
symptoms later in their childhood 
(Sly et al., 2010) 
3. Occupational asthma 
Predominantly, occupational asthma 
is seen among adults and is IgE 
mediated (Fabbri et al., 1994) 
4. Tobacco smoke 
Tobacco smoke decreases lung 
function in asthma patients, increase 
asthma severity and reduces 
likelihood of asthma control 
(Strachan et al., 1998) 
5.Air pollutants 
Children raised in polluted 
environment have a lower lung 
function(Gauderman et al., 2004) 
                            Host factors           Environmental factors                                                        
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1.11 Asthma management 
1.11.1 Aims of asthma management 
Asthma has a significant impact on individuals, their families and society. Although 
there is no cure of asthma however, appropriate management most often results in 
the achievement of its control. The aims of asthma management according to GINA, 
2011 are 
1. Recognize asthma 
2. Abolish asthma symptoms   
3. Restore normal or best possible airway function 
4. Reduce morbidity and mortality 
The management of asthma can be approached in different ways depending on 
various forms of asthma treatment and taking in to account cultural preferences and 
health care systems. However, above mentioned aims aid in diagnosis of asthma, its 
treatment, avoiding precipitating factors and by doing so will assist in reducing 
morbidity and mortality of asthma. 
1.11.2 Approach for asthma management 
The approaches for asthma management in order to achieve aims of asthma 
management are as follows 
1. Education of patient and family 
2. Avoidance of precipitating factors 
3. Use of lowest convenient dose of asthma medication 
4. Patient response to therapy 
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1.11.2.1 Education of patient and family 
Educating asthma patient and family is often the negligible part of asthma 
management. Education should be an integral part of all interactions between health 
care professional and patient. All patients require certain core information and skills, 
but most education must be personalized and given to the patient in multiple steps. 
Good communication is essential for basis of subsequent good compliance (Cabana 
et al., 2006). Patient education should include following points 
1. Nature of asthma 
2. Preventive measure 
3. Proper use of inhaled drugs and their side effects 
4. Knowledge of preventive and relieving medications 
5. Recognition features of worsening asthma 
6. Proper use of peak flow meter 
7. Self management plan 
1.11.2.2 Avoidance of precipitating factors 
Asthma symptoms may be precipitated by number of factors referred as ―triggers‖ 
that include allergens, viral infections, pollutants and drugs. Reducing exposure to 
some of these categories improves the control of asthma and reduces the need for 
medication. Since many patients react to multiple factors, avoiding these factors 
completely is usually impractical. However, medications used in asthma control have 
important roles as patients with their controlled asthma are less sensitive to risk 
factors (Bateman et al., 2008).  
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1.11.2.3 Asthma medications 
There are two major drug groups to treat asthma (GINA, 2011) 
1. Bronchodilators : For relieving bronchospasm and improve symptoms 
2. Anti-inflammatory drug: For treating bronchial airway inflammation and 
bronchial hyper responsiveness. 
Table 1.1: Medication used for asthma treatment (GINA, 2011) 
Bronchodilator Anti-inflammatory drug 
 
                      1.β2 agonist                  1. Corticosteroid  
(a) Inhaled β2 agonist 
(b) Oral long acting β2 
agonist 
(c) Oral short acting β2 
agonist 
(a) Inhaled corticosteroids 
(b) Systemic 
corticosteroids 
(c) Oral corticosteroids  
   
                2.Anticholinergics                   2. Cromones   
                      3.Methylxanthine   
Other treatment   
(a) Anti-histamines 
(b) Anti-cholinergic 
 
 
1.11.2.4 Patient response to therapy 
Assessment to response to asthma medication should be done as follows  
1. Clinical assessment: Clinical assessment of patient symptoms include sleep 
disturbance, disturbance of daily activity and frequency of daily reliever 
medication (GINA, 2011)  
2. Lung function values: spirometry and peak flow meter (PEF) aid in 
assessment of lung function values. Personal best lung function values 
indicate positive effect of medication on patient (GINA, 2011). 
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1.12 Management of chronic asthma 
Apart from the pharmacological management of asthma, non pharmacological 
management of chronic and acute asthma remains similar, that includes educating 
patient and family, identifying and avoiding predisposing risk factors, assessing lung 
function values and other parameters to assess the response to current asthma 
pharmacotherapy.  
The effective chronic asthma management requires assessing patient asthma control. 
Each patient should be assessed for asthma control for current treatment regimen. 
Patient asthma control is classified as ―controlled‖, ―partial controlled‖ and 
―uncontrolled‖ based on patient clinical parameters (GINA, 2011). Patient current 
asthma control and current treatment determines the selection of pharmacological 
treatment. For example, if asthma is not under control on current treatment regimen, 
treatment should be stepped up until control is achieved. If control is maintained for 
at least three months, treatment can be stepped down with aims of establishing the 
lowest step dose of treatment that maintains control. Figure 1.2 describes the scheme 
for step up and step down treatment. 
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Step 1 Step 2 Step 3 Step 4 Step 5 
As needed rapid acting β agonist 
 
 
 
Controller 
option* 
Select one Select one To step 
3,select one or 
more 
To step 4 add 
either 
Low dose 
inhaled 
ICS** 
Low dose ICS 
plus long 
acting β 
agonist 
Medium or 
high dose ICS 
plus long 
acting β 
agonist 
Oral 
gulcocorticosteroid 
(lowest dose) 
Leukotriene 
modifier 
Medium or 
high dose ICS 
 
Low dose ICS 
plus 
Leukotriene 
modifier 
Leukotriene 
modifier 
 
Sustained 
release 
theophylline 
Anti-IgE treatment 
Low dose ICS 
plus sustained 
release 
theophylline. 
*Recommended treatment (shaded box), **Inhaled corticosteroids 
Figure 1.2: Management based on asthma control as per GINA 2011 guideline (GINA, 
2011) 
 
1.13 Management of acute asthma  
Acute management of asthma initially requires assessment for severity of asthma 
exacerbations. Once severity of disease is established, asthma is managed 
Level of control Treatment action 
Controlled Maintain and find lowest controlling step 
Partially controlled Consider stepping up to gain control 
Uncontrolled Step up till controlled 
Exacerbated Treat as acute asthma attack in emergency 
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accordingly. A working scheme for acute management of asthma is described in 
Figure 1.3 
Initial assessment 
History, physical examination (heart rate, respiratory rate, PEF or FEV1, Oxygen 
saturation) 
Initial treatment 
 Oxygen to achieve Oxygen saturation 
 Inhaled rapid acting β agonist continuously for one hour 
 Systemic gulcocorticosteroid if no immediate response, or if patient took oral 
gulcocorticosteroid, or if episode is less severe.  
 Sedation in contraindicated. 
Reassess after one hour 
Physical examination, PEF, O2 saturation and other test needed 
 
Criteria for moderate episode 
PEF: 60-80 % of personal best, physical 
examination 
Treatment: 
Oxygen, Inhaled β agonist and 
Anticholinergics, Oral 
gulcocorticosteroid 
Criteria for severe episode 
PEF<60 % of personal best, physical 
examination. 
Treatment: 
Oxygen, Inhaled β agonist and inhaled 
Anticholinergics, systemic 
gulcocorticosteroid, intravenous 
magnesium 
 
Reassess after 1-2 hours 
Good response 
PEF:> 70 %, physical 
examination, O2 Saturation 
>90 % 
Incomplete response 
PEF<60 %, physical 
examination,O2 saturation 
not improving. 
Poor response 
PEF:<30 %, physical 
examination 
Discharge patient with 
appropriate medications 
Admit to acute care 
setting 
Oxygen, Inhaled β agonist, 
systemic 
gulcocorticosteroid, IV 
magnesium, Monitor PEF, 
O2 saturation, pulse 
Admit to intensive 
care 
Oxygen, inhaled β 
agonist, 
Anticholinergics, IV 
gulcocorticosteroid, IV 
theophylline 
Figure 1.3: Scheme for management for acute asthma management as per 
GINA 2011 guideline (GINA, 2011) 
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1.14 Economic burden of asthma 
Patients suffering from asthma may require lifelong medications due to the chronic 
nature of disease. Under use of medications often results in emergency visits and 
contributes substantially to health care system. It is essential to understand and 
identify medicine regimen that are not only based on clinical success and safety but 
are cost effective as well thereby adding the importance for value for money. The 
asthma cost in the United States of America grew from about USD 53 billion to USD 
56 billion from year 2002 to 2007, with an increase of 6 % (American academy  of 
allergy asthma and immunology, 2011). Cost associated with asthma in Europe is 
approximately USD 21.65 billion annually, of which productivity loss accounts for 
55 %, outpatient care 22 %, anti-asthmatic drugs 20 % and accounts 3 % for inpatient 
representing a significant economic burden (Russels, 2003). Asthma affects directly 
and indirectly by treatment cost to the healthcare system and also by days lost to 
work. The number of disability adjusted life years (DALYs) lost due to asthma has 
been estimated as 15 million per year globally, similar to that of diabetes, cirrhosis of 
liver and schizophrenia (Global burden of asthma, 2011). A study assessing cost of 
asthma in Asia pacific region reported that the average cost of treating asthma per 
patient in Malaysia among 404 subjects was USD 108 (SD ±13) (Lai et al., 2006), 
with asthma population in Malaysia more than 1.8 million, the study indicate major 
economic burden of asthma in Malaysia.  
1.15 Application of pharmacoeconomics in disease management  
Pharmacoeconomics (PE) is defined as the prescription and analysis of the cost of 
drug treatment to healthcare system and community (Bootman et al., 1991). PE 
analysis provides tools for identifying, measuring and evaluating the impact of 
alternative drug therapies and other medical interventions. 
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Pharmacoeconomic analysis can be calculated according to different prospective, 
these include: 
1. Society, in which all types of cost are included. 
2. Provider (Physician, Pharmacist). 
3. Payer (Government, insurances and employers). 
4. Patients (only out of pocket money of patient is measured) (Choi et al., 
2002).  
1.15.1 Direct cost 
Direct cost is associated with treatment and hospitalization of an asthma patient and 
depends on disease severity, complying with medication and cost of health care.  The 
largest component includes the cost of hospitalization whereas cost associated to 
physicians makes up the smallest component (Barnes et al., 1996). 
1.15.2 Direct non-medical cost  
Monetary expenses that are paid at the result of illness (Schulman et al., 2001) these 
include transportation from place to place, cost of meals, parking etc. 
1.15.3 Physicians cost 
Three studies classifying cost in association with general and specialist practitioners, 
reports physicians costs 22 % of which 75 % cost is related to general practitioners 
(GP) and 25 % to specialists (Mellis et al., 1991). Therefore, improving patient 
management by General practitioners can reduce emergency visit and save money in 
long term. 
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1.15.4 Drug cost 
Drug cost makes 37 % of total direct cost of asthma and represents a major cost 
proportion for mild to moderate asthma patients.  Lack of treatment compliance on 
the behalf of patients results in morbidity and emergency visits.  A study indicates 15 
% of patients took medications as directed by doctors during 80 % period of study 
(Bosley et al., 1994). Understanding patient factors in not complying with drug 
regimens and helping patients in understanding their medication could improve 
patient compliance. Thereby reducing emergency visits and reducing associated cost.  
1.15.5 Hospital cost 
Patients with moderate to severe asthma who fail to comply with prophylactic 
medication generally make most of proportion of hospital cost. The total hospital 
cost is 20-25 % of total direct cost. Inpatients make the major component of hospital 
cost (70-85 %), while emergency room treatment was around 14-18 %. Outpatient 
treatment accounted for the smallest proportion of hospital cost (Barnes et al., 1996). 
1.15.6 Other direct cost 
This includes cost in treating asthma co-morbidities, nursing home cost, cost of home 
care and expenditures on alternative medicine. 
1.15.7 Indirect cost 
Indirect cost includes cost associated with loss of productivity, premature retirement 
and time spent by others caring for sick. Children account a high percentage of 
indirect cost (Weiss et al., 1992). In Malaysia, the duration of work lost to asthma is 
4.2 days per episode and for school is 2.4 days per episode, indicating significant 
morbidity and socio economic impact of disease (Rugayah et al., 1997). Since, 
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asthma is not curable and can greatly limit patients‘ quality of life, this contributes to 
intangible cost. Improving patient quality of life and their view about the disease can 
have a positive effect on overall status of patients. 
1.16 Factors contributing to sub-optimal control of asthma 
A number of research studies have been conducted to identify factors that affect the 
sub-optimal control of asthma. The major contributing factors are as follows 
 Lack of knowledge regarding different aspects of disease (Doerschug et al., 
1999). 
 Under diagnosis and under treatment (Gibson et al., 2010). 
 Patient related factors that include anxiety regarding side effects, 
forgetfulness and awkwardness of taking medication (Wöller et al., 1993). 
 Age and employment status of doctors; young and self-employed physicians 
are likely to likely to adopt guideline and attend educational programs. 
(Sarrell et al., 2002). 
 Lack of resources, organizational constraints and lack of reimbursement 
(Naish et al., 1995). 
 Lack of physician‘s awareness regarding recommended published clinical 
practice guideline (Bhogal et al., 2010). 
 Environmental factors; seasonal changes and exposure to allergens 
(Silverman et al., 2003). 
 Respiratory tract infections and co existing complications (Korhonen et al., 
2001). 
 Unawareness of correct inhaler technique by health care professionals and 
most patients (National Asthma Council Australia, 2008). 
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 Limited access and affordability of medication (Kotwani, 2009; Serra-Batlles 
et al., 1998). 
1.17 Conceptual frame work 
The above discussion about non adherence towards guideline and poor control of 
asthma can be summarized in Figure 1.4 
 
Figure 1.4: Factors liable for poor asthma control 
 
 
Doctor Non-Adherence to 
Asthma Guideline 
Attitude Knowledge Prescription 
Patterns 
Patient Factors Medical 
Environmental 
factors 
Poor Asthma Control 
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1.18 Study objective 
1.18.1 General objective 
The general objective of current study is to find out how well doctors know about the 
medication, pharmacological management recommendations of GINA 2011 
guideline for management of asthma at emergency and respiratory department. To 
what extent doctors accept and practice them and to explore association between 
doctors demographics, their attitude, and knowledge about GINA 2011 for the 
management of asthma and their actual practices and to calculate the cost of treating 
asthma in emergency and respiratory department. 
1.18.2 Specific objectives 
Following are the main specific objectives of current study 
1. To evaluate doctor knowledge, attitude and practices on medication 
recommendation of GINA asthma guideline 2011 at Hospital Pulau Pinang 
(HPP). To evaluate factors that affect asthma management 
2. To evaluate the relationship between doctor knowledge and clinical practices. 
3. To evaluate direct cost in associated with asthma treatment. 
1.19 Significance of Study 
  1. The current study will provide information about the doctor current knowledge 
and attitudes regarding the clinical practice guideline. 
  2. Information will serve as an important foundation in identifying the gap between 
the clinical practice guidelines and actual clinical practices. 
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  3. The study will provide information about different factors affecting the 
adherence rate to clinical practice guideline. 
  4. The study will provide information about the prescribing patterns at HPP. 
  5. The study will provide fundamental information, which will act as logical step 
for developing interventions in order to increase adherence to clinical practice 
guidelines. 
 7.  The study is a step towards system development and implementation of clinical 
practice guidelines in Malaysia. 
 
 
 
 
 
 
 
 
 
 
 
 
